Home › UFLEX › Filing
🔔 Get instant alerts when UFLEX files quarterly results on BSE Start free trial →
UFLEX Limited (UFLEX)

Earnings Presentation - REVISED

Filed: 16 Nov 2026, 13:25 IST Exchange: BSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2 FY27 - Consolidated revenue grew 26.1% YoY to Rs. 48,694 Mn; normalized EBITDA rose 94.8% YoY to Rs. 7,588 Mn with margin expansion of 550 bps to 15.6% - Normalized PAT surged 682.8% YoY to Rs. 2,106 Mn with margin at 4.3% (+360 bps YoY) - H1 FY27 revenue up 31.9% YoY; normalized EBITDA up 85.7% with 450 bps margin expansion - Capex of Rs. 5,689 Mn in Q2 FY27; major projects include aseptic plant in Egypt commissioning H2 FY27 - Packaging films volume grew 3.0% YoY; strong growth in MEA, Americas, and India - Debt profile stable; net debt Rs. 90.39 Bn with Net Debt/Normalized EBITDA at 3.42x - Focus on sustainable growth with recycling plant commissioned in Noida and new facilities ramping up
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 UFLEX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add UFLEX to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on UFLEX Limited

Important. The summary above is generated automatically from UFLEX Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.